Published in Oncol Lett on June 23, 2017
Global cancer statistics, 2002. CA Cancer J Clin (2005) 119.22
Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology (1988) 8.08
Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. Int J Radiat Oncol Biol Phys (2000) 4.99
Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis. Ann Intern Med (2003) 3.88
Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest (2007) 3.36
Noninvasive staging of non-small cell lung cancer: a review of the current evidence. Chest (2003) 3.16
Investigation on the role of integrated PET/MRI for target volume definition and radiotherapy planning in patients with high grade glioma. Radiother Oncol (2014) 2.08
Metastases from non-small cell lung cancer: mediastinal staging in the 1990s--meta-analytic comparison of PET and CT. Radiology (1999) 1.88
Definition of gross tumor volume in lung cancer: inter-observer variability. Radiother Oncol (2002) 1.52
A phase II comparative study of gross tumor volume definition with or without PET/CT fusion in dosimetric planning for non-small-cell lung cancer (NSCLC): primary analysis of Radiation Therapy Oncology Group (RTOG) 0515. Int J Radiat Oncol Biol Phys (2010) 1.26
Evaluation of a target contouring protocol for 3D conformal radiotherapy in non-small cell lung cancer. Radiother Oncol (1999) 1.20
2-[Fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography versus whole-body diffusion-weighted MRI for detection of malignant lesions: initial experience. Ann Nucl Med (2007) 1.17
Factors associated with false-positive staging of lung cancer by positron emission tomography. Ann Thorac Surg (2000) 1.06
Radiographic and anatomic basis for prostate contouring errors and methods to improve prostate contouring accuracy. Int J Radiat Oncol Biol Phys (2009) 1.05
A study of prostate delineation referenced against a gold standard created from the visible human data. Radiother Oncol (2007) 1.03
Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results. J Thorac Cardiovasc Surg (2008) 0.95
Using diffusion-weighted MR imaging for tumor detection in the collapsed lung: a preliminary study. Eur Radiol (2008) 0.95
MRI simulation for radiotherapy treatment planning. Med Phys (2012) 0.95
MRI target delineation may reduce long-term toxicity after prostate radiotherapy. Acta Oncol (2013) 0.88
Differentiation of central lung tumor from postobstructive lobar collapse by rapid sequence computed tomography. J Thorac Imaging (1991) 0.86
Diffusion-weighted imaging is superior to positron emission tomography in the detection and nodal assessment of lung cancers. Ann Thorac Surg (2011) 0.86
18F-FDG PET definition of gross tumor volume for radiotherapy of lung cancer: is the tumor uptake value-based approach appropriate for lymph node delineation? Int J Radiat Oncol Biol Phys (2010) 0.86
Critical review of PET-CT for radiotherapy planning in lung cancer. Crit Rev Oncol Hematol (2005) 0.84
Alterations in anatomic and functional imaging parameters with repeated FDG PET-CT and MRI during radiotherapy for head and neck cancer: a pilot study. BMC Cancer (2015) 0.83
Conformal radiotherapy for lung cancer: interobservers' variability in the definition of gross tumor volume between radiologists and radiotherapists. Radiat Oncol (2009) 0.83
Evaluation of patients with round atelectasis using 2-[18F]-fluoro-2-deoxy-D-glucose PET. J Comput Assist Tomogr (1998) 0.82
Guidelines for the role of FDG-PET/CT in lung cancer management. J Infect Public Health (2012) 0.82
PET and PET-CT in radiation treatment planning for lung cancer. Expert Rev Anticancer Ther (2010) 0.79
[Optimization of radiotherapy planning for non-small cell lung cancer (NSCLC) using 18FDG-PET]. Nuklearmedizin (2002) 0.78
Differentiation of central lung cancer from atelectasis: comparison of diffusion-weighted MRI with PET/CT. PLoS One (2013) 0.77
Converting from CT- to MRI-only-based target definition in radiotherapy of localized prostate cancer: A comparison between two modalities. Strahlenther Onkol (2015) 0.76
Intrapatient comparison of 2-deoxy-2-[F-18]fluoro-D-glucose with positron emissiontomography/computed tomography to Tc-99m fanolesomab (NeutroSpec) for localization of infection. Mol Imaging Biol (2007) 0.76